ATE406158T1 - Verwendung von vitamin c zur behandlung der charcot-marie-tooth krankheit - Google Patents

Verwendung von vitamin c zur behandlung der charcot-marie-tooth krankheit

Info

Publication number
ATE406158T1
ATE406158T1 AT03753643T AT03753643T ATE406158T1 AT E406158 T1 ATE406158 T1 AT E406158T1 AT 03753643 T AT03753643 T AT 03753643T AT 03753643 T AT03753643 T AT 03753643T AT E406158 T1 ATE406158 T1 AT E406158T1
Authority
AT
Austria
Prior art keywords
marie
vitamin
tooth disease
relates
charcot
Prior art date
Application number
AT03753643T
Other languages
English (en)
Inventor
Michel Fontes
Edith Passage
Veronique Sanguedolce
Jean-Chretien Noreel
Original Assignee
Univ Aix Marseille Ii
Inst Nat Sante Rech Med
Ass Fr Contre Les Myopathies
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aix Marseille Ii, Inst Nat Sante Rech Med, Ass Fr Contre Les Myopathies filed Critical Univ Aix Marseille Ii
Application granted granted Critical
Publication of ATE406158T1 publication Critical patent/ATE406158T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
AT03753643T 2002-07-16 2003-07-15 Verwendung von vitamin c zur behandlung der charcot-marie-tooth krankheit ATE406158T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0208966A FR2842422B1 (fr) 2002-07-16 2002-07-16 Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations

Publications (1)

Publication Number Publication Date
ATE406158T1 true ATE406158T1 (de) 2008-09-15

Family

ID=29797453

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03753643T ATE406158T1 (de) 2002-07-16 2003-07-15 Verwendung von vitamin c zur behandlung der charcot-marie-tooth krankheit

Country Status (10)

Country Link
US (1) US7649017B2 (de)
EP (1) EP1526850B1 (de)
JP (1) JP2005537264A (de)
AT (1) ATE406158T1 (de)
AU (1) AU2003271807A1 (de)
CA (1) CA2492368A1 (de)
DE (1) DE60323234D1 (de)
ES (1) ES2312804T3 (de)
FR (1) FR2842422B1 (de)
WO (1) WO2004006911A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2065038A1 (de) 2007-11-30 2009-06-03 Pharnext Neue therapeutische Ansätze zur Behandlung der Charcot-Marie-Tooth Krankheit
EP2065821A1 (de) * 2007-11-30 2009-06-03 Pharnext Neue Krankheitsbehandlung durch Vorhersage von Arzneimittelverbindungen
EP2135607A1 (de) 2008-06-18 2009-12-23 Pharnext Kombination aus Pilocarpin und Methimazol zur Behandlung der Charcot-Marie-Tooth Krankheit und verwandten Erkrankungen
EP2263665A1 (de) * 2009-06-02 2010-12-22 Pharnext Neue Zusammensetzungen zur Behandlung von CMT und verwandten Erkrankungen
US9393241B2 (en) 2009-06-02 2016-07-19 Pharnext Compositions for treating CMT and related disorders
AU2010290795B2 (en) * 2009-09-04 2015-12-10 Munisekhar Medasani Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same
FR2978963A1 (fr) 2011-08-11 2013-02-15 Ascorbix Nouveaux derives des furanones et composition pharmaceutique les contenant
CN105473131A (zh) 2013-06-05 2016-04-06 法奈克斯公司 用于组合的活性药物成分的稳定口服溶液
KR102526648B1 (ko) * 2015-08-21 2023-04-27 삼성전자주식회사 2,5-디히드록시벤젠술폰산을 포함하는 신경세포의 수초화를 촉진하기 위한 조성물 및 그의 용도
US10383870B2 (en) 2016-06-10 2019-08-20 Pharnext Early treatment of CMT disease
CN109731005A (zh) * 2019-02-19 2019-05-10 珠海壮元健康研究院有限公司 2-O-β-D-单糖基-L-抗坏血酸在防治神经退行性疾病药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB890638A (en) * 1957-06-11 1962-03-07 Albert B Chatzinoff Compositions for combating retinitis pigmentosa
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
US5762922A (en) * 1994-01-31 1998-06-09 Ludwig Institute For Cancer Research Antioxidants and intracellular gluthathione raising agents for therapeutic treatments
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications
FR2727117A1 (fr) * 1994-11-18 1996-05-24 Geffard Michel Utilisation de conjugues de la polylysine pour la preparation de medicaments utiles dans le traitement des maladies neurodegeneratives et des affections degeneratives a caractere autoimmun
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
DE19629803A1 (de) * 1996-07-24 1998-01-29 Woerwag Pharma Gmbh Arzneimittel zur Behandlung von Neuropathien
IL136303A (en) * 1997-11-24 2004-02-08 Procter & Gamble History -5 (-2 Imidazolinylamino) - Banimidazole, preparation and use as an α-adororeceptor agonists
US6569419B2 (en) * 2000-02-29 2003-05-27 Zymogenetics, Inc. Methods for promoting production of myelin by Schwann cells
US6683192B2 (en) * 2000-03-30 2004-01-27 Curis, Inc. Small organic molecule regulators of cell proliferation

Also Published As

Publication number Publication date
WO2004006911A3 (fr) 2004-04-08
ES2312804T3 (es) 2009-03-01
WO2004006911A2 (fr) 2004-01-22
US20050187290A1 (en) 2005-08-25
EP1526850B1 (de) 2008-08-27
EP1526850A2 (de) 2005-05-04
AU2003271807A1 (en) 2004-02-02
FR2842422B1 (fr) 2006-06-30
DE60323234D1 (de) 2008-10-09
AU2003271807A8 (en) 2004-02-02
JP2005537264A (ja) 2005-12-08
CA2492368A1 (fr) 2004-01-22
US7649017B2 (en) 2010-01-19
FR2842422A1 (fr) 2004-01-23

Similar Documents

Publication Publication Date Title
ATE396973T1 (de) Benzylether- und benzylamino-beta-sekretase- hemmer zur behandlung von alzheimer-krankheit
DE602005025517D1 (de) Herstellung und anwendung von biphenyl-4-yl-carbonylaminosäurederivaten zur behandlung von obesitas
NO20053077L (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
ATE443043T1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
ATE414556T1 (de) Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten
ATE395871T1 (de) Marknagel zur behandlung von proximalen oberschenkelknochenbrüchen
ATE500855T1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
ATE329587T1 (de) Zusammensetzungen zur verwendung bei der behandlung der osteoporose und/oder der entzündlichen gelenkerkrankungen
MY140132A (en) Thiazolidin-4-one derivatives for use in the treatment of anemias
EA200601212A1 (ru) Ингибиторы фосфодиэстеразы, получение и их терапевтическое применение
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ATE406158T1 (de) Verwendung von vitamin c zur behandlung der charcot-marie-tooth krankheit
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
NO20076405L (no) Anvendelse av 24-nor-UDCA
ATE380558T1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
ATE447963T1 (de) Verwendung von lavendelöl zur prophylaxe und behandlung von somatisierungsstörungen und von posttraumatischer stresserkrankung
CY1110156T1 (el) Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης
DE602004027923D1 (de) Zusammensetzung mit notoginseng radix extrakt zur prävention und behandlung von arthritis als wirksamer inhaltsstoff
ATE417035T1 (de) Vitamin-d3-analoga zur prävention undbehandlung von knochenerkrankungen
TNSN06147A1 (en) Use of cathepsin k inhibitors for treating of severe bone loss diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties